Immunome
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Immunome generated cash of -$7,568,000, which is more than the previous year. Cash used in financing activities reached the amount of $116,408,000 last year. Net change in cash is therefore $78,356,000.
Cash Flow
| 2018 | -7.40M | -228K | -551K |
|---|---|---|---|
| 2019 | -9.6M | -233K | 10.77M |
| 2020 | -12.13M | -586K | 49.94M |
| 2021 | -18.22M | -79K | 27.76M |
| 2022 | -28.69M | -248K | 32K |
| 2023 | -7.56M | -30.48M | 116.40M |
IMNM Cash Flow Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 20.42M | 49.32M | 39.86M | 2.64M | 1.70M | 9.88M |
Operating activities | ||||||
Net income | -106.80M | -36.89M | -24.71M | -17.83M | -10.44M | -7.84M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 728K | 631K | 755K | 755K | 615K | 521K |
Stock-based compensation expense | 6.22M | 5.33M | 3.44M | 621K | 14K | 11K |
| Deferred income tax benefit | 6.22M | 5.33M | 3.44M | 621K | 14K | 11K |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -608K | -677K | 1.78M | 504K | 75K | 146K |
Cash generated by operating activities | -7.56M | -28.69M | -18.22M | -12.13M | -9.6M | -7.40M |
Investing activities | ||||||
Purchases Of Investments | -38.92M | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -831K | -248K | -79K | -586K | -233K | -228K |
Acquisitions Net | 9.27M | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -30.48M | -248K | -79K | -586K | -233K | -228K |
Financing activities | ||||||
Common Stock Issued | 34K | 32K | 27.88M | 44.85M | 4.62M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | -49K | -35K | 0 |
Repayments of term debt | 0 | 0 | -113K | -451K | 6.18M | -551K |
Cash used in financing activities | 116.40M | 32K | 27.76M | 49.94M | 10.77M | -551K |
Net Change In Cash | 78.35M | -28.90M | 9.46M | 37.22M | 941K | -8.18M |
Cash at end of period | 98.77M | 20.42M | 49.32M | 39.86M | 2.64M | 1.70M |
| Data source | Data source | Data source | Data source |